Gene Replacement

Neurogene Doses First Two Patients in Pediatric US Trial

Taysha Cleared to Dose Second Patient in Gene Therapy Trial

Taysha Gene Therapies Doses First Rett Syndrome Patient

Neurogene Shares Key Information on Gene Therapy Clinical Trial with the Rett Community

Taysha Provides Update For Their Rett Syndrome Gene Replacement Program

Neurogene Receives FDA Approval for Gene Replacement Clinical Trial for Rett Syndrome

What We Accomplished in 2022

What We Learned from Taysha’s Clinical Trial Community Update

Taysha Gene Therapies Shares Rett Syndrome Community Statement on its Collaboration with Astellas Gene Therapies

Taysha Announces Collaboration with Astellas Gene Therapies

A Conversation with Neurogene's Leadership

Neurogene Advances a Rett Gene Replacement Program that Got Its Start at RSRT

Town Hall: When will there be a cure for Rett syndrome?

Taysha Gene Therapies Shares Rett Syndrome Community Statement on its Clinical Trial

Monica’s Perspective on the Novartis News

Novartis Terminates Their Rett Syndrome Gene Replacement Program

Outcomes of a Marathon FDA Meeting on the Safety of Gene Replacement

Taysha Gene Therapies Shares Letter to the Rett Syndrome Community